FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2082860500> ?p ?o ?g. }

• W2082860500 endingPage "407" @default.
• W2082860500 startingPage "400" @default.
• W2082860500 abstract "Primary mediastinal large B-cell lymphoma (PMBCL) is a rare malignancy that has been reported in young individuals, especially young women. Patients with PMBCL commonly receive rituximab induction. This single-institution study was designed to analyze the clinical benefits of rituximab induction and its impact on postinduction treatments (PITs), especially radiotherapy.The benefits of rituximab induction were evaluated by complete response (CR), early treatment failure, relapse, and overall survival (OS) rates. The impact of the induction therapy on the adoption of PIT was evaluated by the proportion of patients who had received at the last follow up any PIT modality [i.e., radiotherapy or hematopoietic stem cell transplantation (HSCT)], radiotherapy alone, HSCT alone, or both modalities.Between 1999 and 2012, 48 PMBCL patients (29 men, 60%) were identified; they had a median age of 31 years. Twenty-eight patients received rituximab induction; of these, 23 (82%) patients also underwent fludeoxyglucose-positron emission tomography (FDG-PET) evaluation. Rituximab induction was significantly associated with higher rates of CR and OS, and lower rates of early treatment failure and relapse. Regarding PIT, patients with rituximab induction were more likely to receive radiotherapy alone [with rituximab induction (25%) vs. without rituximab induction (5%)], and patients with FDG-PET evaluation were similarly more likely to receive radiotherapy alone [with FDG-PET evaluation (28.6%) vs. without FDG-PET evaluation (0%)]. In multivariate analysis, age older than 60 years [hazard ratio (HR), 16.697; 95% confidence interval (CI), 1.106-252.022; p = 0.042] and rituximab induction (HR, 0.089; 95% CI, 0.012-0.653; p = 0.017) were significantly associated with OS.Rituximab improved the CR and OS rates of patients with PMBCL, but these improvements may be attributable to the increased use of radiotherapy (which may have also resulted from FDG-PET evaluation)." @default.
• W2082860500 created "2016-06-24" @default.
• W2082860500 creator A5005562046 @default.
• W2082860500 creator A5006351473 @default.
• W2082860500 creator A5009514805 @default.
• W2082860500 creator A5015287747 @default.
• W2082860500 creator A5029256082 @default.
• W2082860500 creator A5047098889 @default.
• W2082860500 creator A5049496999 @default.
• W2082860500 creator A5053177813 @default.
• W2082860500 creator A5056084189 @default.
• W2082860500 creator A5084631637 @default.
• W2082860500 date "2015-07-01" @default.
• W2082860500 modified "2023-10-17" @default.
• W2082860500 title "Rituximab induction therapy, survival benefits, and the increasing selection of radiotherapy as the postinduction treatment in patients with primary mediastinal large B-cell lymphoma" @default.
• W2082860500 cites W1605230984 @default.
• W2082860500 cites W1775159394 @default.
• W2082860500 cites W1912693401 @default.
• W2082860500 cites W1964191533 @default.
• W2082860500 cites W1970214140 @default.
• W2082860500 cites W1983240924 @default.
• W2082860500 cites W1989904472 @default.
• W2082860500 cites W1996757133 @default.
• W2082860500 cites W1996837917 @default.
• W2082860500 cites W2001196047 @default.
• W2082860500 cites W2035125470 @default.
• W2082860500 cites W2038470690 @default.
• W2082860500 cites W2045545866 @default.
• W2082860500 cites W2051650384 @default.
• W2082860500 cites W2054274023 @default.
• W2082860500 cites W2062310534 @default.
• W2082860500 cites W2093943670 @default.
• W2082860500 cites W2095891194 @default.
• W2082860500 cites W2102311782 @default.
• W2082860500 cites W2113332344 @default.
• W2082860500 cites W2115774433 @default.
• W2082860500 cites W2116867723 @default.
• W2082860500 cites W2121797481 @default.
• W2082860500 cites W2127682234 @default.
• W2082860500 cites W2133201432 @default.
• W2082860500 cites W2137691920 @default.
• W2082860500 cites W2138265225 @default.
• W2082860500 cites W2143118351 @default.
• W2082860500 cites W2164696411 @default.
• W2082860500 cites W2168681651 @default.
• W2082860500 cites W2169612614 @default.
• W2082860500 cites W2171493516 @default.
• W2082860500 cites W2350274126 @default.
• W2082860500 cites W254931162 @default.
• W2082860500 cites W2605539363 @default.
• W2082860500 doi "https://doi.org/10.1016/j.jcma.2015.02.005" @default.
• W2082860500 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25801492" @default.
• W2082860500 hasPublicationYear "2015" @default.
• W2082860500 type Work @default.
• W2082860500 sameAs 2082860500 @default.
• W2082860500 citedByCount "1" @default.
• W2082860500 countsByYear W20828605002017 @default.
• W2082860500 crossrefType "journal-article" @default.
• W2082860500 hasAuthorship W2082860500A5005562046 @default.
• W2082860500 hasAuthorship W2082860500A5006351473 @default.
• W2082860500 hasAuthorship W2082860500A5009514805 @default.
• W2082860500 hasAuthorship W2082860500A5015287747 @default.
• W2082860500 hasAuthorship W2082860500A5029256082 @default.
• W2082860500 hasAuthorship W2082860500A5047098889 @default.
• W2082860500 hasAuthorship W2082860500A5049496999 @default.
• W2082860500 hasAuthorship W2082860500A5053177813 @default.
• W2082860500 hasAuthorship W2082860500A5056084189 @default.
• W2082860500 hasAuthorship W2082860500A5084631637 @default.
• W2082860500 hasBestOaLocation W20828605001 @default.
• W2082860500 hasConcept C126322002 @default.
• W2082860500 hasConcept C141071460 @default.
• W2082860500 hasConcept C143998085 @default.
• W2082860500 hasConcept C207103383 @default.
• W2082860500 hasConcept C2776611710 @default.
• W2082860500 hasConcept C2779338263 @default.
• W2082860500 hasConcept C2780653079 @default.
• W2082860500 hasConcept C44249647 @default.
• W2082860500 hasConcept C509974204 @default.
• W2082860500 hasConcept C71924100 @default.
• W2082860500 hasConceptScore W2082860500C126322002 @default.
• W2082860500 hasConceptScore W2082860500C141071460 @default.
• W2082860500 hasConceptScore W2082860500C143998085 @default.
• W2082860500 hasConceptScore W2082860500C207103383 @default.
• W2082860500 hasConceptScore W2082860500C2776611710 @default.
• W2082860500 hasConceptScore W2082860500C2779338263 @default.
• W2082860500 hasConceptScore W2082860500C2780653079 @default.
• W2082860500 hasConceptScore W2082860500C44249647 @default.
• W2082860500 hasConceptScore W2082860500C509974204 @default.
• W2082860500 hasConceptScore W2082860500C71924100 @default.
• W2082860500 hasFunder F4320321040 @default.
• W2082860500 hasFunder F4320325620 @default.
• W2082860500 hasFunder F4320327358 @default.
• W2082860500 hasIssue "7" @default.
• W2082860500 hasLocation W20828605001 @default.
• W2082860500 hasLocation W20828605002 @default.
• W2082860500 hasOpenAccess W2082860500 @default.
• W2082860500 hasPrimaryLocation W20828605001 @default.
• W2082860500 hasRelatedWork W1900595920 @default.

• next